These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19840555)

  • 1. A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.
    Kraft-Terry SD; Buch SJ; Fox HS; Gendelman HE
    Neuron; 2009 Oct; 64(1):133-45. PubMed ID: 19840555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 neuroimmunity in the era of antiretroviral therapy.
    Kraft-Terry SD; Stothert AR; Buch S; Gendelman HE
    Neurobiol Dis; 2010 Mar; 37(3):542-8. PubMed ID: 20044002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS.
    Kaul M; Lipton SA
    J Neuroimmune Pharmacol; 2006 Jun; 1(2):138-51. PubMed ID: 18040780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathogenesis of human immunodeficiency virus infection.
    Sillman B; Woldstad C; Mcmillan J; Gendelman HE
    Handb Clin Neurol; 2018; 152():21-40. PubMed ID: 29604978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimmunity, drugs of abuse, and neuroAIDS.
    Burdo TH; Katner SN; Taffe MA; Fox HS
    J Neuroimmune Pharmacol; 2006 Mar; 1(1):41-9. PubMed ID: 18040790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases.
    Yoshioka M; Bradley WG; Shapshak P; Nagano I; Stewart RV; Xin KQ; Srivastava AK; Nakamura S
    Adv Neuroimmunol; 1995; 5(3):335-58. PubMed ID: 8748077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex.
    Nottet HS; Gendelman HE
    Immunol Today; 1995 Sep; 16(9):441-8. PubMed ID: 7546209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.
    Lindl KA; Marks DR; Kolson DL; Jordan-Sciutto KL
    J Neuroimmune Pharmacol; 2010 Sep; 5(3):294-309. PubMed ID: 20396973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection.
    Buzhdygan T; Lisinicchia J; Patel V; Johnson K; Neugebauer V; Paessler S; Jennings K; Gelman B
    J Neuroimmune Pharmacol; 2016 Jun; 11(2):279-93. PubMed ID: 26829944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration.
    Mamik MK; Asahchop EL; Chan WF; Zhu Y; Branton WG; McKenzie BA; Cohen EA; Power C
    J Neurosci; 2016 Oct; 36(41):10683-10695. PubMed ID: 27733618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the inflammasomes in HIV-associated neuroinflammation and neurocognitive disorders.
    Katuri A; Bryant J; Heredia A; Makar TK
    Exp Mol Pathol; 2019 Jun; 108():64-72. PubMed ID: 30922769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroregulatory events follow adaptive immune-mediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis.
    Poluektova L; Gorantla S; Faraci J; Birusingh K; Dou H; Gendelman HE
    J Immunol; 2004 Jun; 172(12):7610-7. PubMed ID: 15187141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model of HIV-associated neurocognitive disorders: a brain-behavior approach to discover disease mechanisms and novel treatments.
    Tyor WR; Bimonte-Nelson H
    J Neurovirol; 2018 Apr; 24(2):180-184. PubMed ID: 28895064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathogenesis of HIV-1 infection. Outstanding questions.
    Vitkovic L; Tardieu M
    C R Acad Sci III; 1998 Dec; 321(12):1015-21. PubMed ID: 9929782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimmune Crosstalk through Extracellular Vesicles in Health and Disease.
    Delpech JC; Herron S; Botros MB; Ikezu T
    Trends Neurosci; 2019 May; 42(5):361-372. PubMed ID: 30926143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine models for human immunodeficiency virus type 1-associated dementia: the development of new treatment testing paradigms.
    Persidsky Y; Gendelman HE
    J Neurovirol; 2002 Dec; 8 Suppl 2():49-52. PubMed ID: 12491151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration.
    Liu J; Gong N; Huang X; Reynolds AD; Mosley RL; Gendelman HE
    J Immunol; 2009 Mar; 182(6):3855-65. PubMed ID: 19265165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
    Kramer-Hämmerle S; Rothenaigner I; Wolff H; Bell JE; Brack-Werner R
    Virus Res; 2005 Aug; 111(2):194-213. PubMed ID: 15885841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral infection, immune response peptides and sleep.
    Darko DF; Mitler MM; Henriksen SJ
    Adv Neuroimmunol; 1995; 5(1):57-77. PubMed ID: 7795894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection.
    Persidsky Y; Gendelman HE
    J Leukoc Biol; 2003 Nov; 74(5):691-701. PubMed ID: 14595004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.